| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -153.22M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IMVT returned +191.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +74.5% |
| 1 year | +191.1% |
| 5 years | +412.4% |
| All-time high | $49.19 (Nov 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IMVT would be worth today ›No. Immunovant, Inc. has not paid a dividend in the past 12 months.
Immunovant, Inc. stock trades on NASDAQ under the ticker symbol IMVT.
Immunovant, Inc. is part of the Healthcare sector.
Immunovant, Inc. has a market cap of 9.16B USD, based on the latest quote.
